Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Finland | 7 | 2020 | 671 | 0.42 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.32 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.27 | Why? |
| Sindbis Virus | 1 | 2002 | 32 | 0.23 | Why? |
| Alphavirus Infections | 1 | 2002 | 68 | 0.22 | Why? |
| Immunoglobulin A | 3 | 2021 | 3567 | 0.21 | Why? |
| Arthritis, Infectious | 1 | 2002 | 111 | 0.21 | Why? |
| Fluorescence Resonance Energy Transfer | 1 | 2021 | 320 | 0.19 | Why? |
| Sensitivity and Specificity | 7 | 2021 | 22971 | 0.16 | Why? |
| Laboratories, Hospital | 1 | 2020 | 489 | 0.15 | Why? |
| Encephalitis, California | 1 | 2014 | 12 | 0.14 | Why? |
| Molecular Diagnostic Techniques | 2 | 2020 | 4239 | 0.13 | Why? |
| Orthobunyavirus | 1 | 2014 | 53 | 0.13 | Why? |
| Reagent Kits, Diagnostic | 2 | 2021 | 2149 | 0.12 | Why? |
| Culicidae | 1 | 2014 | 239 | 0.12 | Why? |
| Orthomyxoviridae | 1 | 2020 | 1168 | 0.12 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.10 | Why? |
| Nucleic Acid Amplification Techniques | 2 | 2021 | 3388 | 0.10 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.09 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.09 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.08 | Why? |
| Automation, Laboratory | 2 | 2020 | 536 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.07 | Why? |
| Child, Preschool | 4 | 2020 | 36283 | 0.07 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.06 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.06 | Why? |
| Periodicity | 1 | 2002 | 34 | 0.06 | Why? |
| Infant | 2 | 2020 | 30274 | 0.05 | Why? |
| Adult | 8 | 2021 | 244371 | 0.05 | Why? |
| Phosphoproteins | 2 | 2021 | 4346 | 0.05 | Why? |
| Registries | 1 | 2020 | 12327 | 0.05 | Why? |
| Aged, 80 and over | 5 | 2020 | 88759 | 0.05 | Why? |
| Adolescent | 5 | 2020 | 86841 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Child | 4 | 2020 | 70012 | 0.05 | Why? |
| Immunoenzyme Techniques | 1 | 2021 | 448 | 0.05 | Why? |
| Proof of Concept Study | 1 | 2021 | 696 | 0.05 | Why? |
| Random Allocation | 1 | 2021 | 773 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.04 | Why? |
| Humans | 13 | 2021 | 930598 | 0.04 | Why? |
| Tertiary Healthcare | 1 | 2020 | 616 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Aged | 6 | 2021 | 215776 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| False Negative Reactions | 1 | 2021 | 1785 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2002 | 27595 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.03 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.03 | Why? |
| Male | 6 | 2021 | 367725 | 0.03 | Why? |
| Female | 6 | 2021 | 380317 | 0.03 | Why? |
| Recombinant Proteins | 1 | 2021 | 3786 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Forecasting | 1 | 2002 | 4492 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Vero Cells | 1 | 2014 | 14117 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Phylogeny | 1 | 2014 | 13341 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Animals | 1 | 2014 | 78931 | 0.00 | Why? |
Kurkela's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(88)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(169)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_